You're signed outSign in or to get full access.
Nextech Invest, LTD.
CIK:0001595430
Private Equity
$0 AUM
16 holdings
Zurich, V8 (Canton of Zurich), Switzerland
Nextech Invest fuels the success of emerging biotechnology companies worldwide, focusing on transformative cancer medicines.
Investment Strategy
Focus on oncology with a long-term investment perspective.
Latest 13F Filing Activity
Nextech Invest, LTD. filed their most recent 13F report on Jun 30, 2025 disclosing 16 equity positions with a total 13F market value of $528B. The fund increased holdings in Oric Pharmaceuticals Inc., Tango Therapeutics Inc., Kymera Therapeutics Inc. among other positions. Nextech Invest, LTD. reduced exposure to Boundless Bio Inc., Mersana Therapeutics Inc., Alumis Inc. among others.
Top Buys
Top Holdings
Equity Positions (16)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
R RVMD | REVOLUTION MEDICINES INC | 52.92% | $279.64B | 7,601,087 | $35.36 | $36.79 | +$10.87B |
O ORIC | ORIC PHARMACEUTICALS INC | 13.76% | $72.70B | 7,162,637 | $6.78 | $10.15 | +$43.21B |
T TYRA | TYRA BIOSCIENCES INC | 7.35% | $38.81B | 4,055,861 | $9.30 | $9.57 | +$1.10B |
T TNGX | TANGO THERAPEUTICS INC | 5.36% | $28.33B | 5,533,980 | $1.37 | $5.12 | +$20.75B |
K KYMR | KYMERA THERAPEUTICS INC | 2.82% | $14.88B | 340,909 | $43.64 | $43.64 | +$14.88B |
Industry Allocation
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+61.1%
PHARMACEUTICAL PREPARATIONS
+41.8%
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more